USD 1.18
(-4.47%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 65.62 Million USD | 86.42% |
2022 | 35.2 Million USD | 2.35% |
2021 | 34.39 Million USD | 113.15% |
2020 | 16.13 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 84.46 Million USD | 15.56% |
2024 Q1 | 73.09 Million USD | 11.39% |
2023 Q3 | 51.43 Million USD | 12.61% |
2023 FY | 65.62 Million USD | 86.42% |
2023 Q1 | 39.35 Million USD | 11.79% |
2023 Q4 | 65.62 Million USD | 27.58% |
2023 Q2 | 45.67 Million USD | 16.07% |
2022 Q1 | 35.65 Million USD | 3.66% |
2022 FY | 35.2 Million USD | 2.35% |
2022 Q2 | 29.23 Million USD | -18.01% |
2022 Q3 | 29.54 Million USD | 1.07% |
2022 Q4 | 35.2 Million USD | 19.14% |
2021 Q3 | 33.97 Million USD | 43.26% |
2021 Q4 | 34.39 Million USD | 1.24% |
2021 Q2 | 23.71 Million USD | 18.39% |
2021 FY | 34.39 Million USD | 113.15% |
2021 Q1 | 20.03 Million USD | 24.13% |
2020 Q2 | 8.24 Million USD | 348.02% |
2020 Q1 | 1.84 Million USD | 0.0% |
2020 Q3 | 9.06 Million USD | 9.86% |
2020 Q4 | 16.13 Million USD | 78.08% |
2020 FY | 16.13 Million USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -1270.271% |
Safety Shot Inc | 1.86 Million USD | -3409.914% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 56.855% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 40.984% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -869.464% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -102.966% |
Dynavax Technologies Corporation | 53.29 Million USD | -23.143% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -463.433% |
Pacira BioSciences, Inc. | 104.35 Million USD | 37.114% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -1044.303% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -1044.303% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -8004.036% |
Journey Medical Corporation | 10.2 Million USD | -542.985% |
Alpha Teknova, Inc. | 11.59 Million USD | -466.008% |
Procaps Group, S.A. | 96.83 Million USD | 32.231% |
Theratechnologies Inc. | 6.06 Million USD | -981.817% |
Harrow Health, Inc. | 10.86 Million USD | -503.874% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -2313.498% |
Biofrontera Inc. | 10.9 Million USD | -501.604% |
DURECT Corporation | 2.21 Million USD | -2857.323% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 15.225% |
Cronos Group Inc. | 30.33 Million USD | -116.299% |
OptiNose, Inc. | 8.05 Million USD | -714.99% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -6562299900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -1051.476% |
Organogenesis Holdings Inc. | 28.25 Million USD | -132.269% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -2351.261% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1323.689% |
Radius Health, Inc. | 278.64 Million USD | 76.449% |
Universe Pharmaceuticals INC | 3.34 Million USD | -1862.841% |
ProPhase Labs, Inc. | 3.84 Million USD | -1608.487% |
Phibro Animal Health Corporation | 265.91 Million USD | 75.321% |
Procaps Group S.A. | 96.83 Million USD | 32.231% |
Alvotech | 74.43 Million USD | 11.836% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 98.109% |
Rockwell Medical, Inc. | 5.87 Million USD | -1017.748% |
Aytu BioPharma, Inc. | 12.63 Million USD | -419.457% |
SIGA Technologies, Inc. | 64.21 Million USD | -2.187% |
Tilray Brands, Inc. | 252.08 Million USD | 73.968% |
Lifecore Biomedical, Inc. | 39.97 Million USD | -64.144% |
Shineco, Inc. | 1.58 Million USD | -4031.065% |
PetIQ, Inc. | 159.3 Million USD | 58.808% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 43053.174% |
Incannex Healthcare Limited | -10.01 Million USD | 755.247% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | -71.339% |
Alimera Sciences, Inc. | 1.87 Million USD | -3392.443% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | -74.131% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -3974.973% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -1363.819% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25700.072% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -532.206% |
Hempacco Co., Inc. | 2.54 Million USD | -2480.912% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 11.836% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -37.304% |
Lantheus Holdings, Inc. | 64.02 Million USD | -2.489% |
Currenc Group, Inc. | 732.91 Thousand USD | -8853.747% |
Kamada Ltd. | 87.74 Million USD | 25.213% |
Indivior PLC | 141.79 Million USD | 53.721% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -13519.251% |
Flora Growth Corp. | 8.5 Million USD | -671.309% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25700.072% |
Evolus, Inc. | 10.99 Million USD | -496.681% |
HUTCHMED (China) Limited | 50.25 Million USD | -30.572% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 37.994% |
Akanda Corp. | 1.28 Million USD | -4999.332% |